Vivos Therapeutics to Share Q1 2025 Results and Updates Soon

Vivos Therapeutics Prepares for Q1 2025 Financial Disclosure

Vivos Therapeutics, Inc. (NASDAQ: VVOS), a pioneering company in the medical devices sector, is gearing up to release its financial results for the first quarter of 2025. This announcement is anticipated to take place following the market's closure on a Thursday in May 2025.

The management team is set to hold a conference call that day at 5:00 p.m. Eastern Time, allowing investors and stakeholders to get insights into the company’s recent milestones and future outlook.

How to Join the Conference Call

For those wishing to listen in, participants can join the Vivos investor conference call by calling (800) 717-1738 or, for international participants, (646) 307-1865. Additionally, a replay of the call will be available shortly after it concludes. To access the replay, call (844) 512-2921 for domestic callers and (412) 317-6671 for international ones, using the passcode 1124460. Note that the replay will remain accessible until the end of May 2025.

There will be a live webcast available on the Vivos website, ensuring that anyone interested can listen in. An archive of the event will also be made available for 30 days after the live conversation.

Introducing Vivos Therapeutics

Founded in 2016 and based in Littleton, CO, Vivos Therapeutics focuses on addressing sleep-related breathing disorders, particularly obstructive sleep apnea (OSA) and snoring issues affecting adults and children aged 6 to 17. The company has garnered attention for its innovative technology, which has been FDA-cleared for various treatments.

Vivos’ devices not only provide a new level of care for those suffering from OSA but also reflect the company's commitment to improving the understanding and treatment of breathing and sleep health. With over a billion individuals worldwide grappling with this condition, many remain undiagnosed. Vivos aims to bridge this gap by delivering clinically effective solutions.

The Vivos Method: A New Approach

At the heart of Vivos’ offering is the Vivos Method, a proprietary and clinically validated solution that is noninvasive, nonsurgical, and does not rely on pharmaceuticals. This innovative approach aims to empower patients to breathe easier and live healthier lives. Vivos partners with dental and medical professionals to collaboratively address the complex challenges posed by sleep disorders.

The unique CARE devices from Vivos Therapeutics have been the first to gain FDA clearance for treating severe OSA in adults and moderate to severe OSA in children, illustrating their groundbreaking position within the industry.

Challenges and Opportunities Ahead

Vivos recognizes that while strides have been made in treating sleep disorders, there is still considerable work to be done within the broader medical community. The misconception that sleep issues are simply inconveniences rather than serious health concerns calls for greater awareness and comprehensive solutions.

In response, Vivos is innovating continuously, focusing on education and raising awareness among healthcare providers and patients alike. This mission is essential, as many existing treatments may not effectively tackle the underlying causes of OSA.

Contacting Vivos Investor Relations

For those who wish to engage further with Vivos, Bradford Amman serves as the Chief Financial Officer and Investor Relations contact. He is readily available to provide details and insights regarding the company's strategies and performance. Individuals can reach out via email with any inquiries they have.

Frequently Asked Questions

What is the primary focus of Vivos Therapeutics?

Vivos Therapeutics is mainly focused on developing innovative treatments for sleep-related breathing disorders, particularly obstructive sleep apnea.

When will Vivos release its first quarter 2025 financial results?

The company plans to release its financial results after market close on a Thursday in May 2025.

How can I access the investor conference call?

Dial (800) 717-1738 or (646) 307-1865 for international callers. A replay will also be available using passcode 1124460.

What is the Vivos Method?

The Vivos Method is a noninvasive treatment approach for obstructive sleep apnea that has been clinically validated.

Who can I contact for more information on Vivos?

Bradford Amman is the CFO and Investor Relations contact, and he can be reached via email for inquiries.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.